Clincosm LogoSign in Get a demo

glioblastoma

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The PALSUR-study: Palliative Care Versus Surgery in High-grade

Recruiting
  • Glioblastoma
  • +3 more
  • Palliative Care
  • +2 more
  • San Francisco, California
  • +7 more
Nov 18, 2023

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma

Recruiting
  • Glioblastoma
  • +4 more
  • Tumor resection
  • Tumor biopsy
  • San Francisco, California
  • +7 more
Nov 18, 2023

Supramaximal Resection Versus Maximal Resection for High-Grade

Recruiting
  • Glioblastoma
  • +11 more
  • Supramaximal resection
  • Maximal safe resection
  • San Francisco, California
  • +7 more
Nov 1, 2023

Glioblastoma Trial in San Francisco (Cannabidiol (CBD), Placebo)

Not yet recruiting
  • Glioblastoma
  • Cannabidiol (CBD)
  • Placebo
  • San Francisco, California
    University of California San Francisco Brain Tumor Center
Feb 21, 2023

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Glioblastoma Trial in United States (Abemaciclib, Surgery)

Active, not recruiting
  • Glioblastoma
  • Los Angeles, California
  • +6 more
Dec 28, 2022

Glioblastoma, Recurrent Glioblastoma Trial in San Francisco (RMC-5552)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • San Francisco, California
    University of California, San Francisco
Nov 28, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)

Active, not recruiting
  • Glioblastoma
  • LY2157299 monohydrate
  • +2 more
  • Birmingham, Alabama
  • +26 more
Oct 18, 2022

Glioblastoma Trial in Canada, China, United States (drug, other, radiation)

Active, not recruiting
  • Glioblastoma
  • Enzastaurin Hydrochloride
  • +3 more
  • Birmingham, Alabama
  • +62 more
Oct 11, 2022

Glioblastoma Trial in Australia, United States (drug, radiation, biological)

Completed
Has Results
  • Glioblastoma
  • Los Angeles, California
  • +7 more
Oct 3, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

Recruiting
  • Glioblastoma
  • +5 more
  • Ipilimumab
  • +4 more
  • Birmingham, Alabama
  • +19 more
Aug 16, 2022

Glioblastoma Trial in United States (biological, radiation, drug)

Active, not recruiting
  • Glioblastoma
  • INO-5401
  • +4 more
  • Duarte, California
  • +20 more
Aug 8, 2022

Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

Recruiting
  • Glioblastoma
  • Adult-type Diffuse Gliomas
  • Beverly Hills, California
  • +83 more
Jul 25, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • lerapolturev
  • pembrolizumab
  • San Francisco, California
  • +9 more
Nov 30, 2021

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Phoenix, San Francisco (Niraparib, Radiation therapy)

Recruiting
  • Glioblastoma
  • +5 more
  • Phoenix, Arizona
  • +1 more
Dec 7, 2021

Glioblastoma Trial in United States (Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc)

Completed
  • Glioblastoma
  • Ad-RTS-hIL-12
  • +2 more
  • Los Angeles, California
  • +6 more
Nov 3, 2021

Glioblastoma, Grade IV Astrocytoma, Glioblastoma Multiforme Trial in United States (MDNA55)

Completed
  • Glioblastoma
  • +3 more
  • San Francisco, California
  • +6 more
Jan 13, 2021

Glioblastoma Trial in United States (Pembrolizumab, Bevacizumab)

Completed
Has Results
  • Glioblastoma
  • Los Angeles, California
  • +7 more
Nov 30, 2020

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
Has Results
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial in San Francisco (enzastaurin, temozolomide, radiation therapy)

Completed
Has Results
  • Glioblastoma
  • +2 more
  • San Francisco, California
    For additional information regarding investigative sites for thi
Jul 23, 2020